Amazon has agreed to acquire OneMedical, a US-based healthcare provider, for $3.9bn. The Seattle-based giant is looking for growth in adjacent areas as big acquisitions in its core businesses, mainly e-commerce, are highly scrutinised by regulators due to its significant market share.
After lengthy investigations from Brussels, and in order to avoid hefty fines, Amazon offered concessions to regulators on the way its retail business operates. But with the retailer being perceived as a digital monopoly and the subject of past antitrust and data privacy investigations, its foray into healthcare will be far from smooth.
